Product Code: 12497
The bio decontamination market size stood at USD 171.4 million in 2022, and it is on track to hitting USD 294.7 million by 2030, growing at a 7.0% CAGR between 2022 and 2030. P&S Intelligence says the expansion of this industry is owing to the escalating count of surgical procedures, surging cases of HAIs, and growing pharmaceutical and biotechnology sectors.
The largest potential for this industry is in the expanding healthcare sector. With the increasing burden of infections, proper decontamination of medical facilities is a must. Many countries learned this lesson the hard way during the pandemic, when a significant case count was attributed to healthcare facilities that were not properly sanitized.
In 2022, the equipment category accounted for the largest revenue share, of about 55%, owing to the existence of numerous pieces of sanitizing equipment and the advantages related to them.
For example, washer disinfectors are often used in the medical and pharmaceutical sectors to either clean things before application or prepare reusable items (such as surgical instruments) for further sterilization.
Hydrogen Peroxide Sale Produced Most Revenue
The hydrogen peroxide category accounted for the largest market share, of above 40%, in 2022. A variety of microorganisms can be effectively killed using low concentrations of hydrogen peroxide vapors.
Most polymers and adhesives employed in the manufacture of healthcare gadgets are incapable of withstanding high temperatures. Hydrogen peroxide vapor sterilization may be successfully performed at temperatures as low as 4 °C (39 °F).
Furthermore, due to the low D-values associated with hydrogen peroxide vapors, rapid sterilization is feasible. The isolators can be put to more-diverse uses because of the short sterilization time. Additionally, since a pressure vessel is not required with HPV, costs are lower. Moreover, as a result of the peroxide vapors' improved effectiveness, the usage of other chemicals comes down.
HAIs Cases Are Rapidly Increasing in North America
With a share of about 45%, North America is the largest market, attributed to the growing count of surgical procedures and HAI cases and the existence of key players.
In the U.S. and Canada, after heart disease, cancer ranks as the second-most-common cause of death. In contrast to prostate and breast cancer, which are the most-often-diagnosed malignancies in men and women, respectively, lung cancer is the most-common cause of cancer mortality in both sexes.
Moreover, the European region has a significant share, of above 25%, primarily due to the mounting prevalence of HAIs. In the EU each year, over 4 million patients contract a healthcare-related infection.
In Europe, several distinct national-level systems provide healthcare services. As European customers seek more convenience, more alternatives, and shorter wait times, the private healthcare industry is booming.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segment
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by agent
- 1.4.3. Market size breakdown, by type
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
- 6.1. Market Dynamics
- 6.1.1. Trends
- 6.1.2. Drivers
- 6.1.3. Restraints/challenges
- 6.1.4. Impact analysis of drivers/restraints
- 6.2. Impact of COVID-19
- 6.3. Porter's Five Forces Analysis
- 6.3.1. Bargaining power of buyers
- 6.3.2. Bargaining power of suppliers
- 6.3.3. Threat of new entrants
- 6.3.4. Intensity of rivalry
- 6.3.5. Threat of substitutes
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Agent (2017-2030)
- 7.4. Market Revenue, by Type (2017-2030)
- 7.5. Market Revenue, by End User (2017-2030)
- 7.6. Market Revenue, by Region (2017-2030)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Agent (2017-2030)
- 8.4. Market Revenue, by Type (2017-2030)
- 8.5. Market Revenue, by End User (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Agent (2017-2030)
- 9.4. Market Revenue, by Type (2017-2030)
- 9.5. Market Revenue, by End User (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. APAC Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Agent (2017-2030)
- 10.4. Market Revenue, by Type (2017-2030)
- 10.5. Market Revenue, by End User (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. LATAM Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Agent (2017-2030)
- 11.4. Market Revenue, by Type (2017-2030)
- 11.5. Market Revenue, by End User (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. MEA Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Agent (2017-2030)
- 12.4. Market Revenue, by Type (2017-2030)
- 12.5. Market Revenue, by End User (2017-2030)
- 12.6. Market Revenue, by Country (2017-2030)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Agent (2017-2030)
- 13.4. Market Revenue, by Type (2017-2030)
- 13.5. Market Revenue, by End User (2017-2030)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Agent (2017-2030)
- 14.4. Market Revenue, by Type (2017-2030)
- 14.5. Market Revenue, by End User (2017-2030)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Agent (2017-2030)
- 15.4. Market Revenue, by Type (2017-2030)
- 15.5. Market Revenue, by End User (2017-2030)
Chapter 16. France Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Agent (2017-2030)
- 16.4. Market Revenue, by Type (2017-2030)
- 16.5. Market Revenue, by End User (2017-2030)
Chapter 17. U.K. Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Agent (2017-2030)
- 17.4. Market Revenue, by Type (2017-2030)
- 17.5. Market Revenue, by End User (2017-2030)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Agent (2017-2030)
- 18.4. Market Revenue, by Type (2017-2030)
- 18.5. Market Revenue, by End User (2017-2030)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Agent (2017-2030)
- 19.4. Market Revenue, by Type (2017-2030)
- 19.5. Market Revenue, by End User (2017-2030)
Chapter 20. Japan Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Agent (2017-2030)
- 20.4. Market Revenue, by Type (2017-2030)
- 20.5. Market Revenue, by End User (2017-2030)
Chapter 21. China Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Agent (2017-2030)
- 21.4. Market Revenue, by Type (2017-2030)
- 21.5. Market Revenue, by End User (2017-2030)
Chapter 22. India Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Agent (2017-2030)
- 22.4. Market Revenue, by Type (2017-2030)
- 22.5. Market Revenue, by End User (2017-2030)
Chapter 23. Australia Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Agent (2017-2030)
- 23.4. Market Revenue, by Type (2017-2030)
- 23.5. Market Revenue, by End User (2017-2030)
Chapter 24. South Korea Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Agent (2017-2030)
- 24.4. Market Revenue, by Type (2017-2030)
- 24.5. Market Revenue, by End User (2017-2030)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Agent (2017-2030)
- 25.4. Market Revenue, by Type (2017-2030)
- 25.5. Market Revenue, by End User (2017-2030)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Agent (2017-2030)
- 26.4. Market Revenue, by Type (2017-2030)
- 26.5. Market Revenue, by End User (2017-2030)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Agent (2017-2030)
- 27.4. Market Revenue, by Type (2017-2030)
- 27.5. Market Revenue, by End User (2017-2030)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Agent (2017-2030)
- 28.4. Market Revenue, by Type (2017-2030)
- 28.5. Market Revenue, by End User (2017-2030)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Market Revenue, by Product (2017-2030)
- 29.3. Market Revenue, by Agent (2017-2030)
- 29.4. Market Revenue, by Type (2017-2030)
- 29.5. Market Revenue, by End User (2017-2030)
Chapter 30. Competitive Landscape
- 30.1. List of Market Players and Their Offerings
- 30.2. Competitive Benchmarking of Key Players
- 30.3. Product Benchmarking of Key Players
- 30.4. Recent Strategic Developments
Chapter 31. Company Profiles
- 31.1. STERIS plc
- 31.1.1. Business overview
- 31.1.2. Product and service offerings
- 31.1.3. Key financial summary
- 31.2. Ecolab Inc.
- 31.2.1. Business overview
- 31.2.2. Product and service offerings
- 31.2.3. Key financial summary
- 31.3. TOMI Environmental Solutions
- 31.3.1. Business overview
- 31.3.2. Product and service offerings
- 31.3.3. Key financial summary
- 31.4. JCE BIOTECHNOLOGY
- 31.4.1. Business overview
- 31.4.2. Product and service offerings
- 31.5. Fedegari Autoclavi SpA
- 31.5.1. Business overview
- 31.5.2. Product and service offerings
- 31.6. Howorth Air Technology Limited
- 31.6.1. Business overview
- 31.6.2. Product and service offerings
- 31.7. SolidFog Technologies
- 31.7.1. Business overview
- 31.7.2. Product and service offerings
- 31.8. ClorDiSys Solutions Inc.
- 31.8.1. Business overview
- 31.8.2. Product and service offerings
- 31.9. Noxilizer Inc.
- 31.9.1. Business overview
- 31.9.2. Product and service offerings
- 31.10. Zhejiang Tailin bioengineering Co. Ltd.
- 31.10.1. Business overview
- 31.10.2. Product and service offerings
- 31.11. Amira SRL
- 31.11.1. Business overview
- 31.11.2. Product and service offerings
Chapter 32. Appendix
- 32.1. Abbreviations
- 32.2. Sources and References
- 32.3. Related Reports